The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
Open accessAbstract
Growth factors and mitogens use the Ras/Raf/MEK/ERK signaling cascade to transmit signals from their receptors to regulate gene expression and prevent apoptosis. Some components of these pathways are mutated or aberrantly expressed in human cancer (e.g., Ras, B-Raf). Mutations also occur at genes encoding upstream receptors (e.g., EGFR and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL) which transmit their signals through these cascades. Even in the absence of obvious genetic mutations, this pathway has been reported to be activated in over 50% of acute myelogenous leukemia and acute lymphocytic leukemia and is also frequently activated in other cancer types (e.g., breast and prostate cancers). Importantly, this increased expression is associated with a poor prognosis. The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt pathways interact with each other to regulate growth and in some cases tumorigenesis. For example, in some cells, PTEN mutation may contribute to suppression of the Raf/MEK/ERK cascade due to the ability of activated Akt to phosphorylate and inactivate different Rafs. Although both of these pathways are commonly thought to have anti-apoptotic and drug resistance effects on cells, they display different cell lineage specific effects. For example, Raf/MEK/ERK is usually associated with proliferation and drug resistance of hematopoietic cells, while activation of the Raf/MEK/ERK cascade is suppressed in some prostate cancer cell lines which have mutations at PTEN and express high levels of activated Akt. Furthermore the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt pathways also interact with the p53 pathway. Some of these interactions can result in controlling the activity and subcellular localization of Bim, Bak, Bax, Puma and Noxa. Raf/MEK/ERK may promote cell cycle arrest in prostate cells and this may be regulated by p53 as restoration of wild-type p53 in p53 deficient prostate cancer cells results in their enhanced sensitivity to chemotherapeutic drugs and increased expression of Raf/MEK/ERK pathway. Thus in advanced prostate cancer, it may be advantageous to induce Raf/MEK/ERK expression to promote cell cycle arrest, while in hematopoietic cancers it may be beneficial to inhibit Raf/MEK/ERK induced proliferation and drug resistance. Thus the Raf/MEK/ERK pathway has different effects on growth, prevention of apoptosis, cell cycle arrest and induction of drug resistance in cells of various lineages which may be due to the presence of functional p53 and PTEN and the expression of lineage specific factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055229 · Cited by 1,760
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 1×
“In some cells, B-Raf mutations are believed to be initiating events but not sufficient for full-blown neoplastic transformation [122,123].”
BackgroundActivation of Mitogen-activated Protein Kinase by H2O2
Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., & Holbrook, N. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4138 · Cited by 1,212
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO reports · doi:10.1093/embo-reports/kve046 · Cited by 1,210
Chang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402824 · Cited by 1,176
Self-citationShou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria
Wang, H.-G., Rapp, U. R., & Reed, J. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81383-5 · Cited by 766
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Rommel, C., Clarke, B. A., Zimmermann, S., Nuñez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D., & Glass, D. J. (1999) · Science · doi:10.1126/science.286.5445.1738 · Cited by 758
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Self-citationJAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Self-citationHsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., et al. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.004 · Cited by 664
Self-citationWoods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Ley, R., Balmanno, K., Hadfield, K., Weston, C., & Cook, S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301010200 · Cited by 608
MAPK pathways in radiation responses
Dent, P., Yacoub, A., Fisher, P. B., Hagan, M. P., & Grant, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206701 · Cited by 602
The Photobiology of Photodynamic Therapy: Cellular Targets and Mechanisms
Oleinick, N. L., & Evans, H. H. (1998) · Radiation Research · doi:10.2307/3579816 · Cited by 577
Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.
Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sithanandam, G., Rapp, U., Ashworth, A., Marshall, C. J., & Cowley, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06424.x · Cited by 559
Activation of mitogen-activated protein kinase associated with prostate cancer progression.
Gioeli, D. G., Mandell, J. W., Petroni, G. R., Frierson, H. F., & Weber, M. J. (1999) · PubMed · Cited by 541
JNK-Mediated BIM Phosphorylation Potentiates BAX-Dependent Apoptosis
Putcha, G. V., Le, S., Frank, S., Besirli, C. G., Clark, K., Chu, B., Alix, S., Youle, R. J., LaMarche, A., Maroney, A. C., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00355-6 · Cited by 518
Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., & Okumura, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3537 · Cited by 517
Knebel, A., Rahmsdorf, H. J., Ullrich, A., & Herrlich, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00916.x · Cited by 514
Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases
Kamakura, S., Moriguchi, T., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26563 · Cited by 510
Luciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G., & Auberger, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206792 · Cited by 477
Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase
Yan, J., Roy, S., Apolloni, A., Lane, A., & Hancock, J. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24052 · Cited by 477
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S., & Clarke, P. R. (2003) · Nature Cell Biology · doi:10.1038/ncb1005 · Cited by 474
Schittenhelm, M. M., Shiraga, S., Schroeder, A., Corbin, A. S., Griffith, D., Lee, F. Y., Bokemeyer, C., Deininger, M. W. N., Druker, B. J., & Heinrich, M. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2050 · Cited by 468
Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1
Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S., & Schmidt-Ullrich, R. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0283:sariao]2.0.co;2 · Cited by 463
Narayanan, P. K., Goodwin, E. H., & Lehnert, B. E. (1997) · PubMed · Cited by 461
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456
Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
Big Mitogen-activated Protein Kinase 1 (BMK1) Is a Redox-sensitive Kinase
Abe, J.-I., Kusuhara, M., Ulevitch, R. J., Berk, B. C., & Lee, J.-D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16586 · Cited by 438
Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., & Gewirtz, D. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10149-1 · Cited by 436
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Appelbaum, F. R., Slovak, M. L., Willman, C. L., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.11.3589 · Cited by 431
Adriamycin-induced heart failure: mechanisms and modulation
Singal, P., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007094214460 · Cited by 428
Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling
Pouysségur, J., Volmat, V., & Lenormand, P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01135-8 · Cited by 421
Regulation and Role of Raf-1/B-Raf Heterodimerization
Rushworth, L. K., Hindley, A. D., O'Neill, E., & Kolch, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2262-2272.2006 · Cited by 418
Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
Garnett, M. J., Rana, S., Paterson, H., Barford, D., & Marais, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.022 · Cited by 416
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Kojima, K., Konopleva, M., Samudio, I. J., Shikami, M., Cabreira-Hansen, M., McQueen, T., Ruvolo, V., Tsao, T., Zeng, Z., Vassilev, L. T., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0553 · Cited by 407
Yuen, S. T., Davies, H. R., Chan, T. L., Ho, J. W. C., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S. Y., et al. (2002) · PubMed · Cited by 404
Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J. B., & Neckers, L. (1996) · PubMed · Cited by 375
Activation of Raf-1 by 14-3-3 proteins
Fantl, W. J., Muslin, A. J., Kikuchi, A., Martin, J. A., MacNicol, A. M., Grosst, R. W., & Williams, L. T. (1994) · Nature · doi:10.1038/371612a0 · Cited by 367
Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis
Fu, Z., Smith, P. C., Zhang, L., Rubin, M. A., Dunn, R. L., Yao, Z., & Keller, E. T. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.878 · Cited by 364
Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210015200 · Cited by 360
Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
Teramoto, H., Coso, O. A., Miyata, H., Igishi, T., Miki, T., & Gutkind, J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27225 · Cited by 343
The ASK1-MAP Kinase Cascades in Mammalian Stress Response
Matsukawa, J. (2004) · Journal of Biochemistry · doi:10.1093/jb/mvh134 · Cited by 343
Martelli, A. M., Nyåkern, M., Tabellini, G., Bortul, R., Tazzari, P. L., Evangelisti, C., & Cocco, L. (2006) · Leukemia · doi:10.1038/sj.leu.2404245 · Cited by 342
Self-citationApoptosis Meets Signal Transduction: Elimination of a BAD Influence
Gajewski, T. F., & Thompson, C. B. (1996) · Cell · doi:10.1016/s0092-8674(00)81377-x · Cited by 341
Busca, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2900 · Cited by 326
Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species
Lander, H. M., Jacovina, A. T., Davis, R. J., & Tauras, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19705 · Cited by 324
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
The functional Interactions Between the MAPK and p53 Signaling Pathways
Wu, G. S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.614 · Cited by 310
Xiao, L., Pimentel, D. R., Wang, J., Singh, K., Colucci, W. S., & Sawyer, D. B. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00254.2001 · Cited by 300
Endothelial apoptosis in Braf-deficient mice
Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R., Rapp, U. R., & Zimmer, A. (1997) · Nature Genetics · doi:10.1038/ng0797-293 · Cited by 299
Redox regulation of cell signalling
Lander, H. M., Milbank, A. J., Tauras, J. M., Hajjar, D. P., Hempstead, B. L., Schwartz, G. D., Kraemer, R. T., Mirza, U. A., Chait, B. T., Burk, S. C., et al. (1996) · Nature · doi:10.1038/381380a0 · Cited by 297
Harada, H., Quearry, B., Ruiz-Vela, A., & Korsmeyer, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406837101 · Cited by 287
Negative Regulation of the Serine/Threonine Kinase B-Raf by Akt
Guan, K.-L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61518-8 · Cited by 281
Regulation of Raf-1 activation and signalling by dephosphorylation
Dhillon, A. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280
Zhuang, S., Demirs, J. T., & Kochevar, I. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001185200 · Cited by 275
Zhao, Q., & Lee, F. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8355 · Cited by 274
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
Kirkegaard, T., Witton, C. J., McGlynn, L. M., Tovey, S. M., Dunne, B., Lyon, A., & Bartlett, J. M. (2005) · The Journal of Pathology · doi:10.1002/path.1829 · Cited by 268
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
Fransen, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh049 · Cited by 268
Paradoxical activation of Raf by a novel Raf inhibitor
Hall-Jackson, C. A., Eyers, P. A., Cohen, P., Goedert, M., Tom Boyle, F., Hewitt, N., Plant, H., & Hedge, P. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80088-x · Cited by 265
Kornblau, S. M., Womble, M., Qiu, Y. H., Jackson, C. E., Chen, W., Konopleva, M., Estey, E. H., & Andreeff, M. (2006) · Blood · doi:10.1182/blood-2006-02-003475 · Cited by 265
Lee Jr, J., & McCubrey, J. (2002) · Leukemia · doi:10.1038/sj.leu.2402460 · Cited by 251
Self-citationMatsuzawa, A., Nishitoh, H., Tobiume, K., Takeda, K., & Ichijo, H. (2002) · Antioxidants & Redox Signaling · doi:10.1089/15230860260196218 · Cited by 250
Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases
Deng, X., Ruvolo, P., Carr, B., & May, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1578 · Cited by 247
Lin, J., Adam, R. M., Santiestevan, E., & Freeman, M. R. (1999) · PubMed · Cited by 241
Oligomerization activates c-Raf-1 through a Ras-dependent mechanism
Luo, Z., Tzivion, G., Belshaw, P. J., Vavvas, D., Marshall, M., & Avruch, J. (1996) · Nature · doi:10.1038/383181a0 · Cited by 237
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
Blagosklonny, M. (2002) · Leukemia · doi:10.1038/sj.leu.2402415 · Cited by 235
Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function
Qi, X.-J., Wildey, G. M., & Howe, P. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505546200 · Cited by 234
Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor α
Modur, V., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13094 · Cited by 234
Okuno, S., Saito, A., Hayashi, T., & Chan, P. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1745-04.2004 · Cited by 232
Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224
Klotz, L., Pellieux, C., Briviba, K., Pierlot, C., Aubry, J., & Sies, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00255.x · Cited by 222
Conde de la Rosa, L., Schoemaker, M. H., Vrenken, T. E., Buist-Homan, M., Havinga, R., Jansen, P. L. M., & Moshage, H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.034 · Cited by 222
Inhibition of PTPs by H2O2 regulates the activation of distinct MAPK pathways
Lee, K., & Esselman, W. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01000-6 · Cited by 217
Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A., & Sawyers, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5143 · Cited by 216
Zou, Y., Komuro, I., Yamazaki, T., Aikawa, R., Kudoh, S., Shiojima, I., Hiroi, Y., Mizuno, T., & Yazaki, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33592 · Cited by 211
Diaz, B., Barnard, D., Filson, A., MacDonald, S., King, A., & Marshall, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4509 · Cited by 203
Bakin, R. E., Gioeli, D. G., Sikes, R. A., Bissonette, E. A., & Weber, M. J. (2003) · PubMed · Cited by 201
Janssen-Heininger, Y. M. W., Macara, I., & Mossman, B. T. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.5.3452 · Cited by 200
Touyz, R. M., Yao, G., Viel, E., Amiri, F., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00015 · Cited by 197
Cavanaugh, J. E., Ham, J., Hetman, M., Poser, S., Yan, C., & Xia, Z. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00434.2001 · Cited by 196
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
McCarthy, S. A., Samuels, M. L., Pritchard, C. A., Abraham, J. A., & McMahon, M. (1995) · Genes & Development · doi:10.1101/gad.9.16.1953 · Cited by 193
Alexia, C., Fallot, G., Lasfer, M., Schweizer-Groyer, G., & Groyer, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.029 · Cited by 191
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 191
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
Whisler, R. L., Goyette, M. A., Grants, I. S., & Newhouse, Y. G. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1263 · Cited by 182
Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2
Jiménez, L. A., Zanella, C. L., Fung, H., Janssen-Heininger, Y. M. W., Vacek, P., Charland, C., Goldberg, J. L., & Mossman, B. T. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.273.5.l1029 · Cited by 177
Weston, C. R., Balmanno, K., Chalmers, C., Hadfield, K., Molton, S. A., Ley, R., Wagner, E. F., & Cook, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206261 · Cited by 176
Ras signaling in prostate cancer progression
Weber, M. J., & Gioeli, D. G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10683 · Cited by 171
Papaiahgari, S., Kleeberger, S. R., Cho, H.-Y., Kalvakolanu, D. V., & Reddy, S. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408275200 · Cited by 166
Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation
Rao, R. K., & Clayton, L. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00268-1 · Cited by 164
Suzaki, Y., Yoshizumi, M., Kagami, S., Koyama, A. H., Taketani, Y., Houchi, H., Tsuchiya, K., Takeda, E., & Tamaki, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111790200 · Cited by 163
Pritchard, C. A., Bolin, L., Slattery, R., Murray, R., & McMahon, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00548-1 · Cited by 159
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Self-citationLee, J. T., Steelman, L. S., & McCubrey, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1612 · Cited by 156
Self-citationp38 MAP Kinase Mediates Nitric Oxide-induced Apoptosis of Neural Progenitor Cells
Cheng, A., Chan, S. L., Milhavet, O., Wang, S., & Mattson, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107698200 · Cited by 152
Oxidative Stress-induced Phospholipase C-γ1 Activation Enhances Cell Survival
Wang, X., McCullough, K. D., Wang, X.-J., Carpenter, G. F., & Holbrook, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102693200 · Cited by 150
Tournier, C., Thomas, G., Pierre, J., Jacquemin, C., Pierre, M., & Saunier, B. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00587.x · Cited by 149
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
Fry, M. (2001) · Breast Cancer Research · doi:10.1186/bcr312 · Cited by 148
Hindley, A. D., & Kölch, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1575 · Cited by 147
Davis, J. M., Navolanic, P. M., Oppenheimer, C. W., Steelman, L. S., Hu, W., Konopleva, M. Y., Blagosklonny, M. V., & McCubrey, J. A. (2003) · PubMed · Cited by 145
Self-citationEffects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells
Kim, B., Han, M., & Chung, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00514-1 · Cited by 144
Usatyuk, P. V., Vepa, S., Watkins, T., He, D., Parinandi, N. L., & Natarajan, V. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770380025 · Cited by 143
Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi, R. K., Weber, E., McMahon, M., Williams, J. R., Baylin, S. B., Mal, A., Harter, M. L., Dillehay, L. E., Claudio, P. P., Giordano, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci831 · Cited by 142
MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes
Minamino, T., Yujiri, T., Papst, P. J., Chan, E. D., Johnson, G. L., & Terada, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15127 · Cited by 135
Schieke, S. M., Briviba, K., Klotz, L., & Sies, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00372-5 · Cited by 132
Li, F., Li, G., Liu, G., Lee, S. W., & Aaronson, S. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1931 · Cited by 132
Blanc, A., Pandey, N. R., & Srivastava, A. K. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.2.229 · Cited by 128
Ricciardi, M. R., McQueen, T. J., Chism, D. D., Milella, M., Estey, E. H., Kaldjian, E. P., Sebolt, J. S., Konopleva, M. Y., & Andreeff, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403859 · Cited by 125
Self-citationSheikh, M. S., Antinore, M. J., Huang, Y. K., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202292 · Cited by 123
Matroule, J., Carthy, C. M., Granville, D. J., Jolois, O., Hunt, D. W. C., & Piette, J. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204546 · Cited by 122
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skórski, T., & Calabretta, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.1995 · Cited by 116
Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53
Lee, S. W., Li, F., Igarashi, M., Ouchi, T., Lu, K. P., & Aaronson, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150024397 · Cited by 115
Analysis of BRAF Mutation in Primary and Metastatic Melanoma
Libra, M., Malaponte, G., Navolanic, P. M., Gangemi, P., Bevelacqua, V., Proietti, L., Bruni, B., Stivala, F., Mazzarino, M. C., Travali, S., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2026 · Cited by 114
Self-citationMcCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 110
Self-citationSerum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
Regulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance
Deng, X., Kornblau, S. M., Ruvolo, P. P., & May, W. S. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024254 · Cited by 103
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
Steelman, L. S., Bertrand, F. E., & McCubrey, J. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.537 · Cited by 102
Self-citationNyåkern, M., Tazzari, P. L., Finelli, C., Bosi, C., Follo, M. Y., Grafone, T., Piccaluga, P. P., Martinelli, G., Cocco, L., & Martelli, A. M. (2005) · Leukemia · doi:10.1038/sj.leu.2404057 · Cited by 99
Self-citationAntiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth
Frogne, T., Jepsen, J. S., Larsen, S. S., Fog, C. K., Brockdorff, B. L., & Lykkesfeldt, A. E. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00946 · Cited by 95
Buder-Hoffmann, S. A., Palmer, C., Vacek, P., Taatjes, D. J., & Mossman, B. T. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.4290 · Cited by 91
ZAP-70-dependent and -independent Activation of Erk in Jurkat T Cells
Griffith, C. E., Zhang, W., & Wange, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10771 · Cited by 91
Zebisch, A., Staber, P. B., Delavar, A., Bodner, C., Hiden, K., Fischereder, K., Janakiraman, M., Linkesch, W., Auner, H. W., Emberger, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0115 · Cited by 90
Nyåkern, M., Cappellini, A., Mantovani, I., & Martelli, A. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0076 · Cited by 90
Self-citationHoyle, P., Moye, P. W., Steelman, L., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H. M., Bosch, E., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401720 · Cited by 89
Self-citationJücker, M., Südel, K. M., Horn, S., Sickel, M. J., Wegner, W., Fiedler, W., & Feldman, R. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402484 · Cited by 87
Shelton, J. G., Steelman, L. S., Lee, J. T., Knapp, S. L., Blalock, W. L., Moye, P. W., Franklin, R. A., Pohnert, S. C., Mirza, A. M., McMahon, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206321 · Cited by 86
Self-citationOncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms
Barnard, D., Diaz, B., Clawson, D. K., & Marshall, M. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202061 · Cited by 86
Friesen, C., Fulda, S., & Debatin, K. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400512 · Cited by 83
Basu, A., & Haldar, S. M. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.659 · Cited by 81
Overexpression of phosphatidylinositol 3-kinase in human lung cancer
Lin, X., Böhle, A., Dohrmann, P., Leuschner, I., Schulz, A., Kremer, B., & Fändrich, F. (2001) · Langenbeck s Archives of Surgery · doi:10.1007/s004230100203 · Cited by 77
Brummer, T., Shaw, P. E., Reth, M., & Misawa, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf588 · Cited by 77
Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells
Ravi, R. K., McMahon, M., Yangang, Z., Williams, J. R., Dillehay, L. E., Nelkin, B. D., & Mabry, M. H. (1999) · Journal of Cellular Biochemistry · Cited by 76
Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H. M., McMahon, M., & McCubrey, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203337 · Cited by 75
Self-citationTong, Z., Singh, G., & Rainbow, A. J. (2002) · PubMed · Cited by 74
Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny, M. V., Prabhu, N. S., & El‐Deiry, W. S. (1997) · PubMed · Cited by 66
Buhl, A. M., Osawa, S., & Johnson, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19828 · Cited by 63
Peyssonnaux, C., Provot, S., Felder‐Schmittbuhl, M., Calothy, G., & Eychène, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7068-7079.2000 · Cited by 62
McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · PubMed · Cited by 62
Self-citationRaf‐1 expression may influence progression to androgen insensitive prostate cancer
Mukherjee, R., Bartlett, J. M. S., Krishna, N. S., Underwood, M. A., & Edwards, J. (2005) · The Prostate · doi:10.1002/pros.20211 · Cited by 57
P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells
Chang, F., & McCubrey, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204564 · Cited by 50
Self-citationShelton, J. G., Moye, P. W., Steelman, L. S., Blalock, W. L., Lee, J. T., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2403052 · Cited by 49
Self-citationMantovani, I., Cappellini, A., Tazzari, P. L., Papa, V., Cocco, L., & Martelli, A. M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20628 · Cited by 47
Self-citationShelton, J. G., Steelman, L. S., Abrams, S. L., Bertrand, F. E., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1009 · Cited by 47
Self-citationMiltenberger, R. J., Farnham, P., Smith, D. E., Stommel, J. M., & Cornwell, M. M. (1995) · PubMed · Cited by 45
Antiapoptosis potential of bcl-2 oncogene by dephosphorylation
Haldar, S., Jena, N., & Croce, C. M. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-061 · Cited by 44
Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Bryan, B. A., Cook, P., & McCubrey, J. A. (2005) · Blood · doi:10.1182/blood-2004-09-3683 · Cited by 41
Self-citationEffect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter
Kim, S., Lee, S., Kwak, N.-H., Kang, C., & Chung, B. (1996) · Cancer Letters · doi:10.1016/0304-3835(95)04023-4 · Cited by 39
Blagosklonny, M. V. (1999) · Leukemia · doi:10.1038/sj.leu.2401623 · Cited by 39
Martínez‐Lorenzo, M. J., Anel, A., Monleón, I., Sierra, J. J., Piñeiro, A., Naval, J., & Álava, M. A. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00142-9 · Cited by 37
Hamden, K. E., Whitman, A. G., Ford, P. W., Shelton, J. G., McCubrey, J. A., & Akula, S. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403532 · Cited by 37
Self-citationYasinska, I. M., Kozhukhar, A. V., & Sumbayev, V. V. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.06.004 · Cited by 37
Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection
Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Shelton, J. G., & McCubrey, J. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207643 · Cited by 34
Self-citationAcoustical Signal Processing in the Central Auditory System
Glendenning, K. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01320-4 · Cited by 34
Blagosklonny, M. V. (1998) · International Journal of Cancer · Cited by 33
Raf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells
Chang, F., Steelman, L. S., & McCubrey, J. A. (2002) · Cell Cycle · doi:10.4161/cc.1.3.128 · Cited by 31
Self-citationAbdelmohsen, K., von Montfort, C., Stuhlmann, D., Gerber, P. A., Decking, U. K. M., Sies, H., & Klotz, L. (2005) · Biological Chemistry · doi:10.1515/bc.2005.027 · Cited by 27
Binding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity
Du, J., Cai, S. H., Shi, Z., & Nagase, F. (2004) · Cell Research · doi:10.1038/sj.cr.7290214 · Cited by 25
Lee, J., Steelman, L. S., & McCubrey, J. A. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.6.1637 · Cited by 25
Self-citationHamden, K. E., Ford, P. W., Whitman, A. G., Dyson, O. F., Cheng, S., McCubrey, J. A., & Akula, S. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13381-13390.2004 · Cited by 23
Self-citationAbsence of BRAF Gene Mutation in Non-Melanoma Skin Tumors
Libra, M., Malaponte, G., Bevelacqua, V., Siciliano, R., Castrogiovanni, P., Fulvi, A., Micali, G., Ligresti, G., Mazzarino, M. C., Stivala, F., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2724 · Cited by 21
Self-citationTo be or not to be: a question of B-Raf?
Kölch, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01889-0 · Cited by 14
Contribution of Caspase‐3 Differs by p53 Status in Apoptosis Induced by X‐Irradiation
Kobayashi, D., Tokino, T., & Watanabe, N. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01118.x · Cited by 11
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Role of ROS and Nutritional Antioxidants in Human Diseases
Liu, Z., Ren, Z., Zhang, J., Chuang, C.-C., Kandaswamy, E., Zhou, T., & Zuo, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00477 · Cited by 860
Metadata
- Authors
- McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., Stivala, F., Libra, M., Basecke, J., Evangelisti, C., Martelli, A. M., & Franklin, R. A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 1773
- Issue
- 8
- Pages
- 1263-1284
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2144169031
- Cited by
- 2,284
- References
- 187
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.